Kidney involvement in COVID-19 and rationale for extracorporeal therapies

The prevalence of direct kidney involvement in novel coronavirus disease (COVID-19) is low, but such involvement is a marker of multiple organ dysfunction and severe disease. Here, we explore potential pathways of kidney damage and discuss the rationale for extracorporeal support with various blood...

Descripción completa

Detalles Bibliográficos
Autores principales: Ronco, Claudio, Reis, Thiago
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144544/
https://www.ncbi.nlm.nih.gov/pubmed/32273593
http://dx.doi.org/10.1038/s41581-020-0284-7
_version_ 1783519854835269632
author Ronco, Claudio
Reis, Thiago
author_facet Ronco, Claudio
Reis, Thiago
author_sort Ronco, Claudio
collection PubMed
description The prevalence of direct kidney involvement in novel coronavirus disease (COVID-19) is low, but such involvement is a marker of multiple organ dysfunction and severe disease. Here, we explore potential pathways of kidney damage and discuss the rationale for extracorporeal support with various blood purification strategies in patients who are critically ill with COVID-19.
format Online
Article
Text
id pubmed-7144544
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-71445442020-04-09 Kidney involvement in COVID-19 and rationale for extracorporeal therapies Ronco, Claudio Reis, Thiago Nat Rev Nephrol Comment The prevalence of direct kidney involvement in novel coronavirus disease (COVID-19) is low, but such involvement is a marker of multiple organ dysfunction and severe disease. Here, we explore potential pathways of kidney damage and discuss the rationale for extracorporeal support with various blood purification strategies in patients who are critically ill with COVID-19. Nature Publishing Group UK 2020-04-09 2020 /pmc/articles/PMC7144544/ /pubmed/32273593 http://dx.doi.org/10.1038/s41581-020-0284-7 Text en © Springer Nature Limited 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Comment
Ronco, Claudio
Reis, Thiago
Kidney involvement in COVID-19 and rationale for extracorporeal therapies
title Kidney involvement in COVID-19 and rationale for extracorporeal therapies
title_full Kidney involvement in COVID-19 and rationale for extracorporeal therapies
title_fullStr Kidney involvement in COVID-19 and rationale for extracorporeal therapies
title_full_unstemmed Kidney involvement in COVID-19 and rationale for extracorporeal therapies
title_short Kidney involvement in COVID-19 and rationale for extracorporeal therapies
title_sort kidney involvement in covid-19 and rationale for extracorporeal therapies
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144544/
https://www.ncbi.nlm.nih.gov/pubmed/32273593
http://dx.doi.org/10.1038/s41581-020-0284-7
work_keys_str_mv AT roncoclaudio kidneyinvolvementincovid19andrationaleforextracorporealtherapies
AT reisthiago kidneyinvolvementincovid19andrationaleforextracorporealtherapies

Ejemplares similares